Individual Stock News
1. Federal Pharmaceuticals (03933.HK): Its application for marketing authorization of Smegglutide injection has been accepted.
2. Sanhuan Group (06951.HK) plans to repurchase some of its A-shares with RMB 500 million to RMB 1 billion.
3. Autohome-S (02518.HK) released its third-quarter results: net profit attributable to shareholders was RMB 195 million.
4. Jiali International (01050.HK) issued a profit warning: it expects interim profit attributable to shareholders to increase by approximately 100% year-on-year.
5. China Biopharmaceutical (01177.HK) and Boehringer Ingelheim reached a strategic cooperation agreement with a potential total amount of US$7 billion.
6. A subsidiary of Honghua Group (00196.HK) signed a drilling rig sales agreement with a Central Asian customer for a total amount of approximately US$59 million.
7. Cafe de Coral Holdings Limited (00341.HK) issued a profit warning: It expects interim profit attributable to shareholders to be between HK$95.8 million and HK$105 million, representing a year-on-year increase of 105% to 125%.
8. Guoxing Aerospace announced on the Hong Kong Stock Exchange that it plans to issue approximately 30.12 million H shares in its Hong Kong listing (subject to the exercise of the offering adjustment right and over-allotment option), with an issue price ranging from HK$24.9 per share to HK$33.2 per share. Trading is expected to commence on November 13.
9. First Journey Holdings Limited (00697.HK): Recently, a fund under First Journey Capital, a subsidiary of the Group, invested in the robotics technology company Jianzhi.
